{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:51:44Z","timestamp":1795020704147,"version":"4.10.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/s41569-018-0022-z","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T11:11:48Z","timestamp":1526037108000},"page":"471-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4090-0391","authenticated-orcid":false,"given":"Merry L.","family":"Lindsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis, N. G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 11, 255\u2013265 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91\u2013112 (2016).","journal-title":"Circ. Res."},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-physiol-012110-142230","volume":"73","author":"JA Dixon","year":"2011","unstructured":"Dixon, J. A. & Spinale, F. G. Myocardial remodeling: cellular and extracellular events and targets. Annu.\u00a0Rev. Physiol. 73, 47\u201368 (2011).","journal-title":"Annu. Rev. Physiol."},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.116.309916","volume":"119","author":"FG Spinale","year":"2016","unstructured":"Spinale, F. G. et al. Crossing into the next frontier of cardiac extracellular matrix research. Circ. Res. 119, 1040\u20131045 (2016).","journal-title":"Circ. Res."},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yjmcc.2015.11.028","volume":"93","author":"SA Clarke","year":"2016","unstructured":"Clarke, S. A., Richardson, W. J. & Holmes, J. W. Modifying the mechanics of healing infarcts: Is better the enemy of good? J. Mol. Cell. Cardiol. 93, 115\u2013124 (2016).","journal-title":"J. Mol. Cell Cardiol."},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/bs.pmbts.2017.02.001","volume":"147","author":"KY DeLeon-Pennell","year":"2017","unstructured":"DeLeon-Pennell, K. Y., Meschiari, C. A., Jung, M. & Lindsey, M. L. Matrix metalloproteinases in myocardial infarction and heart failure. Prog. Mol. Biol. Transl Sci. 147, 75\u2013100 (2017).","journal-title":"Prog. Mol. Biol. Transl Sci."},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","volume":"87","author":"FG Spinale","year":"2007","unstructured":"Spinale, F. G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 87, 1285\u20131342 (2007).","journal-title":"Physiol. Rev."},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.yjmcc.2015.06.006","volume":"85","author":"AP Voorhees","year":"2015","unstructured":"Voorhees, A. P. et al. Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction. J. Mol. Cell. Cardiol. 85, 229\u2013239 (2015).","journal-title":"J. Mol. Cell Cardiol."},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bcp.2014.04.011","volume":"90","author":"FG Spinale","year":"2014","unstructured":"Spinale, F. G. & Villarreal, F. Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors. Biochem. Pharmacol. 90, 7\u201315 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1161\/CIRCRESAHA.113.300309","volume":"113","author":"FG Spinale","year":"2013","unstructured":"Spinale, F. G. & Zile, M. R. Integrating the myocardial matrix into heart failure recognition and management. Circ. Res. 113, 725\u2013738 (2013).","journal-title":"Circ. Res."},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"H190","DOI":"10.1152\/ajpheart.00243.2016","volume":"311","author":"RP Iyer","year":"2016","unstructured":"Iyer, R. P., Jung, M. & Lindsey, M. L. MMP-9 signaling in the left ventricle following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 311, H190\u2013198 (2016).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physiol.00029.2013","volume":"28","author":"A Yabluchanskiy","year":"2013","unstructured":"Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E. & Lindsey, M. L. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology 28, 391\u2013403 (2013).","journal-title":"Physiology"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fphys.2014.00363","volume":"5","author":"DH Lovett","year":"2014","unstructured":"Lovett, D. H., Chu, C., Wang, G., Ratcliffe, M. B. & Baker, A. J. A. N-terminal truncated intracellular isoform of matrix metalloproteinase-2 impairs contractility of mouse myocardium. Front. Physiol. 5, 363 (2014).","journal-title":"Front. Physiol."},{"key":"22_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068154","volume":"8","author":"DH Lovett","year":"2013","unstructured":"Lovett, D. H. et al. N-Terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. PLoS ONE 8, e68154 (2013).","journal-title":"PLoS ONE"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"H919","DOI":"10.1152\/ajpheart.00577.2012","volume":"303","author":"RP Iyer","year":"2012","unstructured":"Iyer, R. P., Patterson, N. L., Fields, G. B. & Lindsey, M. L. The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am. J. Physiol. Heart Circ. Physiol. 303, H919\u2013H930 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/abio.1994.1186","volume":"218","author":"DE Kleiner","year":"1994","unstructured":"Kleiner, D. E. & Stetler-Stevenson, W. G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218, 325\u2013329 (1994).","journal-title":"Anal. Biochem."},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/10409238.2013.770819","volume":"48","author":"J Vandooren","year":"2013","unstructured":"Vandooren, J., Van den Steen, P. E. & Opdenakker, G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit. Rev. Biochem. Mol. Biol. 48, 222\u2013272 (2013).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/01.CIR.103.17.2181","volume":"103","author":"M Lindsey","year":"2001","unstructured":"Lindsey, M. et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia\/reperfusion. Circulation 103, 2181\u20132187 (2001).","journal-title":"Circulation"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/pmic.200900587","volume":"10","author":"R Zamilpa","year":"2010","unstructured":"Zamilpa, R. et al. Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics 10, 2214\u20132223 (2010).","journal-title":"Proteomics"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1021\/pr100147r","volume":"9","author":"YA Chiao","year":"2010","unstructured":"Chiao, Y. A. et al. In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics. J. Proteome Res. 9, 2649\u20132657 (2010).","journal-title":"J. Proteome Res."},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.jacc.2015.07.035","volume":"66","author":"ML Lindsey","year":"2015","unstructured":"Lindsey, M. L. et al. A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis. J. Am. Coll. Cardiol. 66, 1364\u20131374 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCRESAHA.114.301673","volume":"114","author":"RP Iyer","year":"2014","unstructured":"Iyer, R. P., de Castro Bras, L. E., Jin, Y. F. & Lindsey, M. L. Translating Koch\u2019s postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates. Circ. Res. 114, 860\u2013871 (2014).","journal-title":"Circ. Res."},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/gerona\/glv034","volume":"71","author":"A Yabluchanskiy","year":"2016","unstructured":"Yabluchanskiy, A. et al. Myocardial infarction superimposed on aging: MMP-9 deletion promotes M2 macrophage polarization. J. Gerontol. A Biol. Sci. Med. Sci. 71, 475\u2013483 (2016).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.yjmcc.2016.10.005","volume":"100","author":"RP Iyer","year":"2016","unstructured":"Iyer, R. P. et al. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution. J. Mol. Cell. Cardiol. 100, 109\u2013117 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"H224","DOI":"10.1152\/ajpheart.00453.2017","volume":"314","author":"CA Meschiari","year":"2017","unstructured":"Meschiari, C. A. et al. Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 314, H224\u2013H235 (2017).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCGENETICS.115.001249","volume":"9","author":"KY DeLeon-Pennell","year":"2016","unstructured":"DeLeon-Pennell, K. Y. et al. CD36 is a matrix metalloproteinase-9 substrate that stimulates neutrophil apoptosis and removal during cardiac remodeling. Circ. Cardiovasc. Genet. 9, 14\u201325 (2016).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrcardio.2015.165","volume":"13","author":"X Dai","year":"2016","unstructured":"Dai, X., Kaul, P., Smith, S. C. Jr & Stouffer, G. A. Predictors, treatment, and outcomes of STEMI occurring in hospitalized patients. Nat. Rev. Cardiol. 13, 148\u2013154 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","volume":"107","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg, S. et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107, 1579\u20131585 (2003).","journal-title":"Circulation"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.300502","volume":"112","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ. Res. 112, 675\u2013688 (2013).","journal-title":"Circ. Res."},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1089\/ars.2013.5411","volume":"21","author":"LE Castro Bras de","year":"2014","unstructured":"de Castro Bras, L. E. et al. Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle. Antioxid. Redox Signal. 21, 1974\u20131985 (2014).","journal-title":"Antioxid. Redox Signal"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1139\/cjpp-2015-0019","volume":"93","author":"ML Lindsey","year":"2015","unstructured":"Lindsey, M. L., Zouein, F. A., Tian, Y., Padmanabhan Iyer, R. & de Castro Bras, L. E. Osteopontin is proteolytically processed by matrix metalloproteinase 9. Can. J. Physiol. Pharmacol. 93, 879\u2013886 (2015).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/cphy.c140045","volume":"5","author":"A Takawale","year":"2015","unstructured":"Takawale, A., Sakamuri, S. S. & Kassiri, Z. Extracellular matrix communication and turnover in cardiac physiology and pathology. Compr. Physiol. 5, 687\u2013719 (2015).","journal-title":"Compr. Physiol."},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/cvr\/cvv128","volume":"106","author":"Y Ma","year":"2015","unstructured":"Ma, Y. et al. Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence. Cardiovasc. Res. 106, 421\u2013431 (2015).","journal-title":"Cardiovasc. Res."},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2015.03.054","volume":"185","author":"RP Iyer","year":"2015","unstructured":"Iyer, R. P. et al. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. Int. J. Cardiol. 185, 198\u2013208 (2015).","journal-title":"Int. J. Cardiol."},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1096\/fj.201700450R","volume":"32","author":"S Dehn","year":"2018","unstructured":"Dehn, S. & Thorp, E. B. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair. FASEB J. 32, 254\u2013264 (2018).","journal-title":"FASEB J."},{"key":"22_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2017.11.005","author":"S Ricard-Blum","year":"2017","unstructured":"Ricard-Blum, S. & Vallet, S. D. Fragments generated upon extracellular matrix remodeling: biological regulators and potential drugs. Matrix Biol. \n                    https:\/\/doi.org\/10.1016\/j.matbio.2017.11.005\n                    \n                   (2017).","journal-title":"Matrix Biol."},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/cancers6020796","volume":"6","author":"S Bouchet","year":"2014","unstructured":"Bouchet, S. & Bauvois, B. Neutrophil gelatinase-associated lipocalin (NGAL), pro-matrix metalloproteinase-9 (pro-MMP-9) and their complex pro-MMP-9\/NGAL in leukaemias. Cancers 6, 796\u2013812 (2014).","journal-title":"Cancers"},{"key":"22_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2018.01.018","author":"SA Gharib","year":"2018","unstructured":"Gharib, S. A., Manicone, A. M. & Parks, W. C. Matrix metalloproteinases in emphysema. Matrix Biol. \n                    https:\/\/doi.org\/10.1016\/j.matbio.2018.01.018\n                    \n                   (2018).","journal-title":"Matrix Biol."},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.yjmcc.2012.07.017","volume":"53","author":"R Zamilpa","year":"2012","unstructured":"Zamilpa, R. et al. Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J. Mol. Cell. Cardiol. 53, 599\u2013608 (2012).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/eurheartj\/eht420","volume":"35","author":"G Cerisano","year":"2014","unstructured":"Cerisano, G. et al. Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial. Eur. Heart J. 35, 184\u2013191 (2014).","journal-title":"Eur. Heart J."},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijcard.2015.06.024","volume":"197","author":"G Cerisano","year":"2015","unstructured":"Cerisano, G. et al. Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial. Int. J. Cardiol. 197, 147\u2013153 (2015).","journal-title":"Int. J. Cardiol."},{"key":"22_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-016-9120-2","volume":"13","author":"ML Lindsey","year":"2016","unstructured":"Lindsey, M. L., Hall, M. E., Harmancey, R. & Ma, Y. Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction. Clin. Proteom. 13, 19 (2016).","journal-title":"Clin. Proteom."},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/CIR.0000000000000226","volume":"132","author":"ML Lindsey","year":"2015","unstructured":"Lindsey, M. L. et al. Transformative impact of proteomics on cardiovascular health and disease: a\u00a0scientific statement from the American Heart Association. Circulation 132, 852\u2013872 (2015).","journal-title":"Circulation"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"H724","DOI":"10.1152\/ajpheart.00512.2017","volume":"314","author":"HL Brooks","year":"2018","unstructured":"Brooks, H. L. & Lindsey, M. L. Guidelines for authors and reviewers on antibody use in physiology studies. Am. J. Physiol. Heart Circ. Physiol. 314, H724\u2013H732 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey, M. L. et al. Guidelines for experimental models of myocardial ischemia and infarction. Am. J. Physiol. Heart Circ. Physiol. 314, H812\u2013H838 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"H733","DOI":"10.1152\/ajpheart.00339.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey, M. L., Kassiri, Z., Virag, J. A. I., de Castro Bras, L. E. & Scherrer-Crosbie, M. Guidelines for measuring cardiac physiology in mice. Am. J. Physiol. Heart Circ. Physiol. 314, H733\u2013H752 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/cam4.290","volume":"3","author":"E Buache","year":"2014","unstructured":"Buache, E. et al. Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14. Cancer Med. 3, 1197\u20131210 (2014).","journal-title":"Cancer Med."},{"key":"22_CR48","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.ajpath.2012.01.022","volume":"180","author":"GC Koenig","year":"2012","unstructured":"Koenig, G. C. et al. MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction. Am. J. Pathol. 180, 1863\u20131878 (2012).","journal-title":"Am. J. Pathol."},{"key":"22_CR49","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/carcin\/bgu061","volume":"35","author":"N Tobar","year":"2014","unstructured":"Tobar, N. et al. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells. Carcinogenesis 35, 1770\u20131779 (2014).","journal-title":"Carcinogenesis"},{"key":"22_CR50","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1042\/BJ20151154","volume":"473","author":"L Boon","year":"2016","unstructured":"Boon, L., Ugarte-Berzal, E., Vandooren, J. & Opdenakker, G. Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities. Biochem. J. 473, 1471\u20131482 (2016).","journal-title":"Biochem. J."},{"key":"22_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.20171274","volume":"215","author":"M Hulsmans","year":"2018","unstructured":"Hulsmans, M. et al. Cardiac macrophages promote diastolic dysfunction. J. Exp. Med. 215, 423\u2013440 (2018).","journal-title":"J. Exp. Med."},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCRESAHA.117.311071","volume":"122","author":"L Honold","year":"2018","unstructured":"Honold, L. & Nahrendorf, M. Resident and monocyte-derived macrophages in cardiovascular disease. Circ. Res. 122, 113\u2013127 (2018).","journal-title":"Circ. Res."},{"key":"22_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yjmcc.2015.11.015","volume":"93","author":"M Hulsmans","year":"2016","unstructured":"Hulsmans, M., Sam, F. & Nahrendorf, M. Monocyte and macrophage contributions to cardiac remodeling. J. Mol. Cell. Cardiol. 93, 149\u2013155 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"22_CR54","first-page":"187","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans, M. et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 38, 187\u2013197 (2017).","journal-title":"Eur. Heart J."},{"key":"22_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrcardio.2014.207","volume":"12","author":"RA Boon","year":"2015","unstructured":"Boon, R. A. & Dimmeler, S. MicroRNAs in myocardial infarction. Nat. Rev. Cardiol. 12, 135\u2013142 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"22_CR56","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrcardio.2015.105","volume":"12","author":"LB Daniels","year":"2015","unstructured":"Daniels, L. B. & Maisel, A. S. Cardiovascular biomarkers and sex: the case for women. Nat. Rev. Cardiol. 12, 588\u2013596 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"22_CR57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","volume":"120","author":"J Viereck","year":"2017","unstructured":"Viereck, J. & Thum, T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ. Res. 120, 381\u2013399 (2017).","journal-title":"Circ. Res."},{"key":"22_CR58","doi-asserted-by":"publisher","first-page":"937","DOI":"10.15252\/emmm.201506083","volume":"8","author":"MJ Schloss","year":"2016","unstructured":"Schloss, M. J. et al. The time-of-day of myocardial infarction onset affects healing through oscillations in cardiac neutrophil recruitment. EMBO Mol. Med. 8, 937\u2013948 (2016).","journal-title":"EMBO Mol. Med."},{"key":"22_CR59","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1161\/ATVBAHA.110.214379","volume":"30","author":"CB Anea","year":"2010","unstructured":"Anea, C. B. et al. Matrix metalloproteinase 2 and 9 dysfunction underlie vascular stiffness in circadian clock mutant mice. Arterioscler. Thromb. Vasc. Biol. 30, 2535\u20132543 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"22_CR60","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1002\/jcb.26150","volume":"118","author":"J Lou","year":"2017","unstructured":"Lou, J., Wang, Y., Zhang, Z. & Qiu, W. Activation of MMPs in macrophages by Mycobacterium tuberculosis via the miR-223-BMAL1 signaling pathway. J. Cell. Biochem. 118, 4804\u20134812 (2017).","journal-title":"J. Cell. Biochem."},{"key":"22_CR61","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrcardio.2017.102","volume":"14","author":"RA Kloner","year":"2017","unstructured":"Kloner, R. A. et al. New and revisited approaches to preserving the reperfused myocardium. Nat. Rev. Cardiol. 14, 679\u2013693 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"22_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11357-017-9959-9","volume":"39","author":"CA Meschiari","year":"2017","unstructured":"Meschiari, C. A., Ero, O. K., Pan, H., Finkel, T. & Lindsey, M. L. The impact of aging on cardiac extracellular matrix. Geroscience 39, 7\u201318 (2017).","journal-title":"Geroscience"},{"key":"22_CR63","doi-asserted-by":"publisher","first-page":"18626","DOI":"10.1074\/jbc.M512308200","volume":"281","author":"PE Steen Van den","year":"2006","unstructured":"Van den Steen, P. E. et al. The hemopexin and O-glycosylated domains tune gelatinase B\/MMP-9 bioavailability via inhibition and binding to cargo receptors. J. Biol. Chem. 281, 18626\u201318637 (2006).","journal-title":"J. Biol. Chem."},{"key":"22_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbamcr.2013.12.006","volume":"1843","author":"S O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan, S., Medina, C., Ledwidge, M., Radomski,\u00a0M. W. & Gilmer, J. F. Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance \u2014 NO and MMP-9 interactions. Biochim. Biophys. Acta 1843, 603\u2013617 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"22_CR65","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijcard.2016.10.109","volume":"227","author":"TAA El-Aziz","year":"2017","unstructured":"El-Aziz, T. A. A. & Mohamed, R. H. Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction. Int. J. Cardiol. 227, 524\u2013528 (2017).","journal-title":"Int. J. Cardiol."},{"key":"22_CR66","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/tra.12312","volume":"16","author":"T Duellman","year":"2015","unstructured":"Duellman, T., Burnett, J. & Yang, J. Functional roles of N-linked glycosylation of human matrix metalloproteinase 9. Traffic 16, 1108\u20131126 (2015).","journal-title":"Traffic"},{"key":"22_CR67","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1006\/jmcc.2000.1211","volume":"32","author":"P Rouet-Benzineb","year":"2000","unstructured":"Rouet-Benzineb, P., Gontero, B., Dreyfus, P. & Lafuma,\u00a0C. Angiotensin II induces nuclear factor-\u03baB activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J. Mol. Cell. Cardiol. 32, 1767\u20131778 (2000).","journal-title":"J. Mol. Cell Cardiol."},{"key":"22_CR68","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/jcp.22549","volume":"226","author":"P Poggio","year":"2011","unstructured":"Poggio, P. et al. Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls. J. Cell. Physiol. 226, 2139\u20132149 (2011).","journal-title":"J. Cell. Physiol."},{"key":"22_CR69","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4049\/jimmunol.1301906","volume":"192","author":"P Kothari","year":"2014","unstructured":"Kothari, P. et al. IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages. J. Immunol. 192, 349\u2013357 (2014).","journal-title":"J. Immunol."},{"key":"22_CR70","doi-asserted-by":"publisher","first-page":"44521","DOI":"10.1074\/jbc.M111.282772","volume":"286","author":"JM Hartney","year":"2011","unstructured":"Hartney, J. M., Gustafson, C. E., Bowler, R. P., Pelanda,\u00a0R. & Torres, R. M. Thromboxane receptor signaling is required for fibronectin-induced matrix metalloproteinase 9 production by human and murine macrophages and is attenuated by the Arhgef1 molecule. J. Biol. Chem. 286, 44521\u201344531 (2011).","journal-title":"J. Biol. Chem."},{"key":"22_CR71","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1038\/onc.2009.189","volume":"28","author":"J Dai","year":"2009","unstructured":"Dai, J. et al. Osteopontin induces angiogenesis through activation of PI3K\/AKT and ERK1\/2 in endothelial cells. Oncogene 28, 3412\u20133422 (2009).","journal-title":"Oncogene"},{"key":"22_CR72","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1189\/jlb.0605353","volume":"79","author":"S Chakrabarti","year":"2006","unstructured":"Chakrabarti, S., Zee, J. M. & Patel, K. D. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J. Leukoc. Biol. 79, 214\u2013222 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"22_CR73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1004612","volume":"78","author":"S Chakrabarti","year":"2005","unstructured":"Chakrabarti, S. & Patel, K. D. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J. Leukoc. Biol. 78, 279\u2013288 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"22_CR74","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1074\/jbc.M213071200","volume":"278","author":"A Castrillo","year":"2003","unstructured":"Castrillo, A., Joseph, S. B., Marathe, C., Mangelsdorf, D. J. & Tontonoz, P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278, 10443\u201310449 (2003).","journal-title":"J. Biol. Chem."},{"key":"22_CR75","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1172\/JCI22304","volume":"115","author":"S Matsumura","year":"2005","unstructured":"Matsumura, S. et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J. Clin. Invest. 115, 599\u2013609 (2005).","journal-title":"J. Clin. Invest."},{"key":"22_CR76","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1161\/CIRCULATIONAHA.106.612960","volume":"113","author":"ML Lindsey","year":"2006","unstructured":"Lindsey, M. L. et al. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113, 2919\u20132928 (2006).","journal-title":"Circulation"},{"key":"22_CR77","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cardfail.2003.11.003","volume":"10","author":"IB Squire","year":"2004","unstructured":"Squire, I. B., Evans, J., Ng, L. L., Loftus, I. M. & Thompson, M. M. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J. Card. Fail. 10, 328\u2013333 (2004).","journal-title":"J. Card. Fail."},{"key":"22_CR78","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cardfail.2005.08.002","volume":"12","author":"DR Wagner","year":"2006","unstructured":"Wagner, D. R. et al. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J. Card. Fail. 12, 66\u201372 (2006).","journal-title":"J. Card. Fail."},{"key":"22_CR79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yjmcc.2014.09.007","volume":"76","author":"KY DeLeon-Pennell","year":"2014","unstructured":"DeLeon-Pennell, K. Y. et al. P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9. J. Mol. Cell. Cardiol. 76, 218\u2013226 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"22_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI8768","volume":"106","author":"A Ducharme","year":"2000","unstructured":"Ducharme, A. et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106, 55\u201362 (2000).","journal-title":"J. Clin. Invest."},{"key":"22_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.carpath.2007.12.012","volume":"18","author":"SW Borne van den","year":"2009","unstructured":"van den Borne, S. W. et al. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc. Pathol. 18, 37\u201343 (2009).","journal-title":"Cardiovasc. Pathol."},{"key":"22_CR82","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0024-3205(00)00982-6","volume":"68","author":"AM Romanic","year":"2001","unstructured":"Romanic, A. M., Burns-Kurtis, C. L., Gout, B., Berrebi-Bertrand, I. & Ohlstein, E. H. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. Life Sci. 68, 799\u2013814 (2001).","journal-title":"Life Sci."},{"key":"22_CR83","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0022-2828(05)82390-9","volume":"27","author":"JP Cleutjens","year":"1995","unstructured":"Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V. & Weber, K. T. Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell. Cardiol. 27, 1281\u20131292 (1995).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"22_CR84","doi-asserted-by":"publisher","first-page":"H987","DOI":"10.1152\/ajpheart.2001.281.3.H987","volume":"281","author":"T Etoh","year":"2001","unstructured":"Etoh, T. et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am. J. Physiol. Heart Circ. Physiol. 281, H987\u2013H994 (2001).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR85","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/CIRCULATIONAHA.104.499202","volume":"112","author":"AS Blom","year":"2005","unstructured":"Blom, A. S. et al. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 112, 1274\u20131283 (2005).","journal-title":"Circulation"},{"key":"22_CR86","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejphar.2007.04.036","volume":"568","author":"S Takai","year":"2007","unstructured":"Takai, S. et al. Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters. Eur. J. Pharmacol. 568, 231\u2013233 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"22_CR87","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.yjmcc.2014.04.007","volume":"72","author":"TA Ramirez","year":"2014","unstructured":"Ramirez, T. A. et al. Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects. J. Mol. Cell. Cardiol. 72, 326\u2013335 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"22_CR88","doi-asserted-by":"publisher","first-page":"H232","DOI":"10.1152\/ajpheart.00457.2005","volume":"290","author":"ML Lindsey","year":"2006","unstructured":"Lindsey, M. L. et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 290, H232\u2013H239 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"22_CR89","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/hc0602.103674","volume":"105","author":"ML Lindsey","year":"2002","unstructured":"Lindsey, M. L. et al. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 105, 753\u2013758 (2002).","journal-title":"Circulation"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41569-018-0022-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41569-018-0022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41569-018-0022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:21:45Z","timestamp":1684621305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-018-0022-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1038\/s41569-018-0022-z","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"assertion":[{"value":"11 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}